Avanos Medical, Inc.

AVNSNYSEHealthcare● Active

$25.01

$-0.05(-0.18%)

Market Cap$1.2B

P/E Ratio—

52W High$25.49

52W Low$9.303

Avg Volume1.5M

Open$25.10

Beta1.57

Overview

Avanos Medical, Inc.（AVNS）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

avns · 股价预测 · 8 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 8 位华尔街分析师

Hold

8 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 8 · 买入占比: 12.5%

12 个月目标价

High

$26.00

Consensus

$23.00

-8.0% upside

Low

$20.00

Median: $23 · Last Close: $25.01

Avanos Medical, Inc.（AVNS）的分析师共识为 Hold，基于过去 3 个月内 8 位华尔街分析师的评级。AVNS 的 12 个月平均目标价为 $23.00，相对当前价 $25.01 代表 -8.0% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

Historical priceConsensus $23 (-8.0%)High $26Low $20

Consensus Target

$23.00

-8.0% upside

High Target

$26

4.0%

Low Target

$20

-20.0%

Current Price

$25.01

as of today

Based on analyst price targets, the AVNS stock price prediction for the next 12 months ranges from $20 to $26. The consensus AVNS price forecast of $23.00 implies -8.0% upside from the current price of $25.01.

短期股价预测

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-09	$25.09	↑ 0.33%	$25.08	$25.11

1-day model range: $25.08–$25.11. Peak: $25.11 (+0.33%).

长期股价预测

⚠️ 在满 252 个交易日历史（IPO/上市时间较短）前不展示长期预测；短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

50%50%0%

7Buy

7Neutral

0Sell

RSI (14)66.4Neutral

MACDBULLISH

Refreshes daily from EOD close

Moving Averages · AVNS · Jun 8, 2026

Simple Moving Average (SMA)

MA 5$25.01BUY

MA 10$24.92BUY

MA 20$24.82BUY

MA 50$0.00NEUTRAL

MA 100$0.00NEUTRAL

MA 200$0.00NEUTRAL

Current $AVNS · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$24.99BUY

EMA 10$24.93BUY

EMA 20$24.85BUY

EMA 50$0.00NEUTRAL

EMA 100$0.00NEUTRAL

EMA 200$0.00NEUTRAL

Current $AVNS · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2023-07-25	Keybanc	Downgrade ↓	Overweight→Sector Weight
2023-06-21	Stifel	Maintains	Hold→Hold
2023-05-04	Morgan Stanley	Maintains	Underweight→Underweight
2023-02-22	Morgan Stanley	Maintains	Underweight→Underweight
2023-01-06	Morgan Stanley	Maintains	Underweight→Underweight
2022-11-03	Keybanc	Maintains	Overweight→Overweight
2022-10-11	Morgan Stanley	Maintains	Underweight→Underweight
2022-08-10	Keybanc	Maintains	Overweight→Overweight
2022-07-18	Stifel	Maintains	Hold→Hold
2022-07-15	Morgan Stanley	Maintains	Underweight→Underweight

Keybanc2023-07-25

Downgrade ↓

Overweight→Sector Weight

Stifel2023-06-21

Maintains

Hold→Hold

Morgan Stanley2023-05-04

Maintains

Underweight→Underweight

Morgan Stanley2023-02-22

Maintains

Underweight→Underweight

Morgan Stanley2023-01-06

Maintains

Underweight→Underweight

Keybanc2022-11-03

Maintains

Overweight→Overweight

Morgan Stanley2022-10-11

Maintains

Underweight→Underweight

Keybanc2022-08-10

Maintains

Overweight→Overweight

Stifel2022-07-18

Maintains

Hold→Hold

Morgan Stanley2022-07-15

Maintains

Underweight→Underweight

Wall Street analysts have recently issued updated ratings on Avanos Medical, Inc. (AVNS) stock. Of the recent 47 rating actions, 2 were upgrades and 6 were downgrades. 8 analysts currently cover AVNS.

分析师推荐趋势

Buy ratings1 → 0↓ 1

Hold ratings0 → 1↑ +1

Sell ratings0 → 0

AVNS analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$682M

↓ 1.8% YoY

Revenue Next Year

$685M

↑ 0.4% YoY

EPS This Year

$0.00

EPS Next Year

$1.32

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast AVNS EPS of $0.00 for the current fiscal year, based on estimates from 0 analysts. The AVNS revenue forecast is $682M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

AVNS 股价预测由两类独立数据源支撑：来自 8 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。AVNS 的共识目标价为 $23.00（-8.0% 上行空间），分析师共识为 Hold。

AVNS 的短期预测（明日）为 $25.09（+0.33%）。

Avanos Medical, Inc. 在 NYSE 上市，代码 AVNS。AVNS 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 13% 对应 Hold 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

AVNS 预测 · 8 个问题

根据 8 位华尔街分析师，AVNS 的 12 个月平均目标价为 $23.00，最高 $26.00、最低 $20.00。若有图表，中位目标价可在上方查看。相对当前价 $25.01，隐含约 -8.0% 的上行空间。

AVNS 目标价AVNS 分析师目标价AVNS 12个月目标价目标价 AVNS

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.